Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Septicemia after Chemotherapy for Acute Lymphoblastic Leukemia: A Multicenter Study Chinese Children Cancer Group (CCCG)-ALL-2015

Chi Kong Li, MBBS, MD, Yiping Zhu, MD PhD, JingYan Tang, MD, Xiuli Ju, Runming Jin, MD, Ningling Wang, Yumei Chen, MD, Hui Jiang, PhD, Shaoyan Hu, MD PhD, Hu Liu, MD, Kaili Pan, PhD, Jiaoyang Cai, PhD, Yanjing Tang, PhD, Yingyi He, MD& PhD, Rong Yang, MD, Xiaowen Zhai, MD PhD, Lirong SUN, PhD, Yu Jie, MD

Blood (2019) 134 (Supplement_1): 5080.

https://doi.org/10.1182/blood-2019-123451

Published: 2019

Journal Articles

Genetically Engineered Hematopoietic Progenitors Derived from Human Induced Pluripotent Stem Cells Achieve the Feeder-Free and Robust Production of Neutrophils with the Functional Capacity In Vivo

Masashi Miyauchi, Yusuke ITO, MD, Fumio Nakahara, MD PhD, Fumi Nakamura, MD PhD, Yuki Iwasaki, Taiki Kawagoshi, Yuki Kagoya, MD PhD, Shunya Arai, MD PhD, Mineo Kurokawa, MD PhD

Blood (2019) 134 (Supplement_1): 720.

https://doi.org/10.1182/blood-2019-126348

Published: 2019

Journal Articles

Patterns of Infection and Mortality Associated with Intensive AML Induction Therapy: 10 Year Experience from a Tertiary Cancer Centre in India

Hemanth Kumar, MBBS, MD, Nikita Mehra, MD DM, Prasanth Ganesan, MD DM, Venkatraman Radhakrishnan, MD DM, Manikandan Dhanushkodi, MD DM, Jayachandran P K, MD DM, Trivadi S Ganesan, MD DM, S Krupa Shankar, MD DM, Tenali Gnana Sagar, MD DM, Krishnarathinam Kannan, MD DM

Blood (2018) 132 (Supplement 1): 4008.

https://doi.org/10.1182/blood-2018-99-119919

Published: 2018

Journal Articles

Predictors of Mortality in Neutropenic Enterocolitis Among Children and Young Adults with Acute Myeloid Leukemia in Low Middle Income Countries

Reham Khedr, MD, Mohamed Abdel Waged, Marwa Fathy, MD, Wael Zekri, MD

Blood (2018) 132 (Supplement 1): 5174.

https://doi.org/10.1182/blood-2018-99-114970

Published: 2018

Journal Articles

Infections and Immune System Impairment in Multiple Myeloma: Increasing Frequency of Serious Complications in the "Novel Agents Era"— a Retrospective Real Life Analysis

Lorenza Torti, PhD MD, Annamaria Morelli, MD, Francesco Bacci, MD, Paolo Di Bartolomeo, MD

Blood (2017) 130 (Supplement 1): 1875.

https://doi.org/10.1182/blood.V130.Suppl_1.1875.1875

Published: 2017

Journal Articles

Morbidity Pattern in Sickle Cell Disease in Central Gujarat, India — Single Centre Perspective

Seema S. Bhatwadekar, MD, Shubhangi Vishwas Deshpande, MDMDcine, Shweta Vikas Khadse, BHMS, Bijal Shah, MBBS,DCP, Devenkumar Desai, MBBS DCP

Blood (2017) 130 (Supplement 1): 4785.

https://doi.org/10.1182/blood.V130.Suppl_1.4785.4785

Published: 2017

Journal Articles

Dana Farber Protocol (DFCP) for Treatment of Adolescents and Young Adults with ALL, Single Institution Experience in Saudi Arabia

Amal S. Alabdulwahab, MD, Hussein G. ELSayed, MD, Mohamed Atia Sherisher, MD, Wafa M. Elbjeirami, PhD

Blood (2015) 126 (23): 4918.

https://doi.org/10.1182/blood.V126.23.4918.4918

Published: 2015

Journal Articles

Results of a Phase III Trial Including Arsenic Trioxide Consolidation for Pediatric Patients with Acute Promyelocytic Leukemia (APL): A Report from the Children's Oncology Group Study AAML0631

Matthew A. Kutny, MD, Todd A. Alonzo, PhD, Robert B. Gerbing, MA, Yi-Cheng Wang, MS, Cecilia Fu, MD, Soheil Meshinchi, MD PhD, Alan S. Gamis, MD MPH, James H. Feusner, MD, John Gregory, Jr., MD

Blood (2015) 126 (23): 219.

https://doi.org/10.1182/blood.V126.23.219.219

Published: 2015

Journal Articles

Clofarabine in Combination with High-Dose Cytarabine and Liposomal Daunorubicin in Pediatric AML: Results of a Phase 1B Combination Study By the ITCC Consortium

Christian M. Zwaan, MD PhD, Michael Dworzak, MD PhD, Thomas Klingebiel, MD, Claudia Rössig, MD, Guy Leverger, MD, Jan Stary, Evelina S. de Bont, MDPhD, Satianand Ramnarain, MSc, Yves Bertrand, MD, Benoit Brethon, MD, Brigitte Strahm, MD, Gertjan J. Kaspers, MD PhD, Dirk Reinhardt, MD PhD

Blood (2014) 124 (21): 989.

https://doi.org/10.1182/blood.V124.21.989.989

Published: 2014

Journal Articles

Haploidentical Stem Cell Transplantation (SCT) Using Flamsa Regimen As Salvage Chemotherapy

Meltem Kurt Yuksel, MD, Ayla Gokmen, MD, Muhit Ozcan, MD, Onder Arslan, MD, Osman Ilhan, MD, Devrim Ozbek, MD, Mevlude Kurdal Okcu, Ozlem Koktas

Blood (2014) 124 (21): 5925.

https://doi.org/10.1182/blood.V124.21.5925.5925

Published: 2014

Journal Articles

Ex Vivo Generation of CD4 + Th17 Cells to Prevent and Treat Infection from Antibiotic-Resistant Klebsiella Pneumoniae in Immunocompromised Patients

Pawel Muranski, MD, Manuel Franco-Colon, Dhanalakshmi Chinnasamy, Kong Chen, Scott Stegemann, Jinwen Sui, Sawa Ito, MD, Marianna Sabatino, MD, David F. Stroncek, MD, Tara Palmore, Jay Kolls, A John Barrett, MD

Blood (2014) 124 (21): 2445.

https://doi.org/10.1182/blood.V124.21.2445.2445

Published: 2014

Journal Articles

Ex Vivo Generation Of CD4 + T Cells To Prevent and Treat Infection From Antibiotic-Resistant Klebsiella Pneumoniae In Immunocompromised Patients

Manuel Franco-Colon, Kong Chen, Dhanalakshmi Chinnasamy, Marianna Sabatino, David Stroncek, MD, Sawa Ito, Tara Palmore, Jay Kolls, A. John Barrett, Pawel Muranski

Blood (2013) 122 (21): 2022.

https://doi.org/10.1182/blood.V122.21.2022.2022

Published: 2013

Journal Articles

Induction of B7-H6, a ligand for the natural killer cell–activating receptor NKp30, in inflammatory conditions

Jessica Matta, Myriam Baratin, Laurent Chiche, Jean-Marie Forel, Céline Cognet, Guillemette Thomas, Catherine Farnarier, Christelle Piperoglou, Laurent Papazian, Damien Chaussabel, Sophie Ugolini, Frédéric Vély, Eric Vivier

Blood (2013) 122 (3): 394–404.

https://doi.org/10.1182/blood-2013-01-481705

Published: 2013

Includes: Supplemental data

Journal Articles

Implementation of An Aggressive Risk Stratified Treatment Protocol for Children and Adolescents with Acute Lymphoblastic Leukemia in a Developing Country

Samar A. Muwakkit, MD, Carol Al-Aridi, MD, Ahmad Samra, MD, Raya Saab, MD, Rami Mahfouz, MD, MPH, Chantal Farra, MD, Sima Jeha, MD, Miguel R. Abboud, MD

Blood (2011) 118 (21): 876.

https://doi.org/10.1182/blood.V118.21.876.876

Published: 2011

Journal Articles

Graft-Versus-Host Disease Alters Intestinal Microbial Ecology by Inhibiting Production of Enteric Defensins

Yoshihiro Eriguchi, Shuichiro Takashima, Noriko Miyake, Yoji Nagasaki, Nobuyuki Shimono, Koichi Akashi, Takanori Teshima

Blood (2010) 116 (21): 244.

https://doi.org/10.1182/blood.V116.21.244.244

Published: 2010

Journal Articles

UKALL 2003, A Randomised Trial Investigating Treatment Reduction for Children and Young Adults with Minimal Residual Disease Defined Low Risk Acute Lymphoblastic Leukaemia

Ajay J. Vora, FRCPATH, Chris Mitchell, FRCPCH, Nicholas Goulden, FRCPATH, Sue Richards, DSc

Blood (2010) 116 (21): 496.

https://doi.org/10.1182/blood.V116.21.496.496

Published: 2010

Journal Articles

The Medicinal and Antitumor Mushroom, Agaricus Blazei Murill, Activates NF-κB Via TLR2 but Not TLR4 In Monocytic Cells, and Stimulates Monocyte-Derived Dendritic Cells (MDDC) to Increased Cell Surface Marker Expression and Cytokine Production, and May Thus Have Adjuvant Effect In MDDC Cancer Vaccines

Geir Hetland, Anne Merete Aaland Tryggestad, Terje Espevik, Liv Ryan, Jon-Magnus Tangen, MD, Egil Johnson, Gunnar Kvalheim

Blood (2010) 116 (21): 3904.

https://doi.org/10.1182/blood.V116.21.3904.3904

Published: 2010

Journal Articles

Risk Profile, Efficacy and Safety of Rituximab in Patients with Relapsed or Refractory Idiopathic Thrombocytopenic Purpura in a Minority Cohort with Long Term Follow up

Shylendra B Sreenivasappa, MD, R. Catchatourian, MD, Barbara Yim, Pharm.D

Blood (2008) 112 (11): 4546.

https://doi.org/10.1182/blood.V112.11.4546.4546

Published: 2008

Journal Articles

Rituximab Therapy for Treatment of Chronic Warm Autoimmune Hemolytic Anemia

Shylendra B Sreenivasappa, MD, Margaret Clare Telfer, MD

Blood (2008) 112 (11): 5386.

https://doi.org/10.1182/blood.V112.11.5386.5386

Published: 2008

Journal Articles

Unacceptable Toxicity of Lenalidomide When Administered to CLL Patients at Higher Doses.

Leslie A. Andritsos, MD, Amy J. Johnson, Ph.D., William Blum, M.D., Cheryl Kefauver, R.N., Farrukh Awan, M.D., Lisa L. Smith, Rosa Lapalombella, Da-Sheng Wang, Robert D. Knight, Ching-Shih Chen, Ph.D., John C. Byrd, M.D.

Blood (2007) 110 (11): 4727.

https://doi.org/10.1182/blood.V110.11.4727.4727

Published: 2007

NARROW

Septicemia after Chemotherapy for Acute Lymphoblastic Leukemia: A Multicenter Study Chinese Children Cancer Group (CCCG)-ALL-2015

Genetically Engineered Hematopoietic Progenitors Derived from Human Induced Pluripotent Stem Cells Achieve the Feeder-Free and Robust Production of Neutrophils with the Functional Capacity In Vivo

Patterns of Infection and Mortality Associated with Intensive AML Induction Therapy: 10 Year Experience from a Tertiary Cancer Centre in India

Predictors of Mortality in Neutropenic Enterocolitis Among Children and Young Adults with Acute Myeloid Leukemia in Low Middle Income Countries

Infections and Immune System Impairment in Multiple Myeloma: Increasing Frequency of Serious Complications in the "Novel Agents Era"— a Retrospective Real Life Analysis

Morbidity Pattern in Sickle Cell Disease in Central Gujarat, India — Single Centre Perspective

Dana Farber Protocol (DFCP) for Treatment of Adolescents and Young Adults with ALL, Single Institution Experience in Saudi Arabia

Results of a Phase III Trial Including Arsenic Trioxide Consolidation for Pediatric Patients with Acute Promyelocytic Leukemia (APL): A Report from the Children's Oncology Group Study AAML0631

Clofarabine in Combination with High-Dose Cytarabine and Liposomal Daunorubicin in Pediatric AML: Results of a Phase 1B Combination Study By the ITCC Consortium

Haploidentical Stem Cell Transplantation (SCT) Using Flamsa Regimen As Salvage Chemotherapy

Ex Vivo Generation of CD4 + Th17 Cells to Prevent and Treat Infection from Antibiotic-Resistant Klebsiella Pneumoniae in Immunocompromised Patients

Ex Vivo Generation Of CD4 + T Cells To Prevent and Treat Infection From Antibiotic-Resistant Klebsiella Pneumoniae In Immunocompromised Patients

Induction of B7-H6, a ligand for the natural killer cell–activating receptor NKp30, in inflammatory conditions

Implementation of An Aggressive Risk Stratified Treatment Protocol for Children and Adolescents with Acute Lymphoblastic Leukemia in a Developing Country

Graft-Versus-Host Disease Alters Intestinal Microbial Ecology by Inhibiting Production of Enteric Defensins

UKALL 2003, A Randomised Trial Investigating Treatment Reduction for Children and Young Adults with Minimal Residual Disease Defined Low Risk Acute Lymphoblastic Leukaemia

Risk Profile, Efficacy and Safety of Rituximab in Patients with Relapsed or Refractory Idiopathic Thrombocytopenic Purpura in a Minority Cohort with Long Term Follow up

Rituximab Therapy for Treatment of Chronic Warm Autoimmune Hemolytic Anemia

Unacceptable Toxicity of Lenalidomide When Administered to CLL Patients at Higher Doses.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only